SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tvardi Therapeutics, Inc. (TVRD) (CIK 0001346830) (TVRD) — Jan 28, 2014

Tvardi Therapeutics, Inc. (TVRD) (CIK 0001346830)
Date: Jan. 28, 2014 · CIK: 0001346830 · Accession: 0001193125-14-023843

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-192230

Date
January 28, 2014
Author
Managing Director
Form
CORRESP
Company
Tvardi Therapeutics, Inc. (TVRD) (CIK 0001346830)

Letter

Re: Cara Therapeutics, Inc.

Underwriters Acceleration Request

January 28, 2014

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-192230)

Ladies and Gentlemen:

As representatives of the several underwriters of the Company’s proposed public offering of common stock, we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m. (EST) on January 30, 2014 or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated January 17, 2014, through the date hereof:

Preliminary Prospectus dated January 17, 2014:

2,325 copies to prospective underwriters, institutional investors, dealers and others

The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934.

Very truly yours,
STIFEL, NICOLAUS & COMPANY, INCORPORATED

Show Raw Text
CORRESP
1
filename1.htm

Underwriters Acceleration Request

 January 28, 2014

Securities and Exchange Commission

 100 F Street, N.E.

Washington, D.C. 20549

Re:
Cara Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-192230)

 Ladies and Gentlemen:

As representatives of the several underwriters of the Company’s proposed public offering of common stock, we hereby join the
Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m. (EST) on January 30, 2014 or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that we have effected the
following distribution of the Company’s Preliminary Prospectus dated January 17, 2014, through the date hereof:

 Preliminary
Prospectus dated January 17, 2014:

 2,325 copies to prospective underwriters, institutional investors, dealers and others

The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters
and dealers that they have complied with and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934.

Very truly yours,

 STIFEL, NICOLAUS & COMPANY, INCORPORATED

PIPER JAFFRAY & CO.

As representatives of the several Underwriters

By:

STIFEL, NICOLAUS & COMPANY, INCORPORATED

By:

/s/ Keith Lister

Name:

Keith Lister

Title:

Managing Director

By:

PIPER JAFFRAY & CO.

By:

/s/ Christie L. Christina

Name:

Christie L. Christina

Title:

Managing Director